• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO PHILIPPINES CORPORATION TERUMO SURFLO INTRAVENOUS CATHETER; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO PHILIPPINES CORPORATION TERUMO SURFLO INTRAVENOUS CATHETER; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Break (1069)
Patient Problems Hemorrhage/Bleeding (1888); Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/18/2024
Event Type  malfunction  
Manufacturer Narrative
A1: patient identifier: cavalier king charles mix puppy.A2: date of birth: requested, not provided.A3b: gender: n/a.A4: weight: 4.8 kgs.A5: ethnicity: not provided animal use.A6: race: not provided animal use.D4: udi: not applicable.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be sent once the investigation is complete.Retention samples were visually checked and confirmed free from any damage or dent on the catheter tube.The retention samples were subjected to catheter tube and catheter hub fitting force wherein the expected result is that either the catheter tube will be removed/separated from the catheter hub, or the catheter tube will break during the test.The catheter tube is made up of radiopaque ethylene tetrafluoroethylene (etfe) and undergo incoming inspection which includes visual inspection and verification of certificate of analysis according to the material specification.A total of twenty-eight (28) complaints were received from the previous two fiscal years to the present for the same issue where the cause was not identified as related to our product or manufacturing process.Based on the result of the initial investigation, we are yet to identify the root cause of the complaint.Evaluation will be conducted once the actual sample is received.The catheter tube condition of our retention samples was visually good and passed the related functional tests.A review of the product's lot history file revealed no issues that were encountered during the production of the reported lots.No corrective action is taken as of this time.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of terumo (philippines) corporation (manufacturer) registration no.3003902955.
 
Event Description
The user facility reported there was a part of the involved iv catheter still in the patient's leg about 3/4 inches up after the removal of the catheter.Estimated blood loss was less than 250cc.The event occurred post-operative.The reported event required medical or surgical intervention.Additional information was received on 19 mar 2024: the catheter has been confirmed to not be in the patient's leg.The catheter was retrieved by surgical intervention.A torniquet was placed high on the leg with the patient sedated, the surgeon opened the leg and surgically removed the piece.The patient had been hospitalized overnight for chocolate ingestion.There was no procedure, only fluid diuresis when the catheter broke.The iv catheter was removed prior to the patient leaving.The patient went home with a pressure wrap in place as the nurse did not realize that the whole catheter did not come out.The owner returned as the bleeding would not stop.The patient was stable.Additional information was received on 02 apr 2024: the catheter placement was successful with no complications.The iv catheter was in place approximately 22 hours.There was no resistance or difficulty observed when the catheter was removed.However, the patient was very wiggly.The immediate impact when the patient returned was that the bleeding would not stop.The leg was cut open, the piece was isolated within the vein.The vein had to be tied off to remove the broken piece and the vein is no longer functional.The patient is doing well.The leg was cut open, the piece was isolated within the vein.The vein had to be tied off to remove the broken piece and the vein is no longer functional.The current condition of the patient is doing well to their knowledge.Additional information was received on 12 apr 2024: there was only one procedure completed to remove the catheter portion from the vein.
 
Manufacturer Narrative
This report is being sent as follow-up no.1 to update section d9, section h3, and to provide the completed investigation results.The actual device has been returned for evaluation.The proximal hub and distal point of the iv catheter were received.The tube was viewed under magnification, and it was observed that the proximal hub was pressed.It was also observed that the distal point was flattened and scratched.Traces of dried medicine and blood were observed inside the needle hub (proximal hub) and tube (distal point).Both points of separation have a clean cut.The retention samples were subjected to catheter tube and catheter hub fitting force wherein the expected result is that either the catheter tube will be removed/separated from the catheter hub, or the catheter tube will break during the test (test is in reference to iso 10555-1).Results were all passed against our specification of >7.845n.Based on the evaluation results, it was confirmed that the points of separation of the proximal hub and distal point ends had a clean cut.It is most likely that the catheter tube was accidentally cut during the removal process.There were no reported issues with the product when it was inserted into the vein or during the 22-hour period it was used, indicating that the device worked properly.There is no evidence that there was a pre-existing defect with the device related to either the materials or the manufacturing process.A review of the product's lot history file revealed no issues that were encountered during the production of the reported lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO SURFLO INTRAVENOUS CATHETER
Type of Device
CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
TERUMO PHILIPPINES CORPORATION
124 east main avenue
laguna technopark
binan
RP 
Manufacturer (Section G)
TERUMO PHILIPPINES CORPORATION
124 east main avenue
laguna, binan
RP  
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
6402040886
MDR Report Key19131147
MDR Text Key341413396
Report Number3003902955-2024-00012
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133280
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberSROX2025V
Device Lot Number230727SF
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received04/18/2024
Supplement Dates Manufacturer Received04/17/2024
Supplement Dates FDA Received05/15/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/27/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age4 MO
Patient SexFemale
Patient Weight5 KG
-
-